Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05119842
NA

APrevent-VOIS-Implant-002 - a Two-Part, Open-Label, Non-Randomized Multicenter Study

Sponsor: APrevent Biotech GmbH

View on ClinicalTrials.gov

Summary

This is a prospective, 2-part, multi-center, open-label, non-randomized clinical trial to assess safety and effectiveness of APrevent® VOIS Implants for the treatment of patients with Unilateral Vocal Fold Paralysis (UVFP). In total 30 evaluable patients are planned to be enrolled.

Official title: Study on the Safety and Effectiveness of APrevent® VOIS Implants for Treatment in Patients With Unilateral Vocal Fold Paralysis (UVFP) - a Two-Part, Open-Label, Non-Randomized Multicenter Study

Key Details

Gender

All

Age Range

18 Years - 80 Years

Study Type

INTERVENTIONAL

Enrollment

30

Start Date

2019-11-13

Completion Date

2026-09

Last Updated

2025-02-06

Healthy Volunteers

Yes

Interventions

DEVICE

APrevent® VOIS-Implant

To compare the voice quality assessed by the change in G-Score from GRBAS-Scale between before and after permanent APrevent® VOIS implantation.

Locations (7)

Mayo Clinic - Phoenix

Phoenix, Arizona, United States

Greater Baltimore Medical Center

Baltimore, Maryland, United States

Cleveland Clinic

Cleveland, Ohio, United States

The University of Texas Health Science Center at Houston

Houston, Texas, United States

Medical University of Vienna

Vienna, Austria

SRH Wald-Klinikum Gera

Gera, Germany

University Medical Center

Hamburg, Germany